Effect of nivolumab combined with definitive chemoradiotherapy on response rate for esophageal cancer: An immune active intrinsic subtype could be its biomarker—The NOBEL trial. This is an ASCO ...

GastroPET: Phase II academic clinical trial evaluating sequential FDG-PET driven preoperative treatment strategy in locally advanced oesophago-gastric cancer in the context of miRNA- and immune-based ...

Conversion surgery, particularly one-anastomosis gastric bypass, delivers greater and more durable weight loss than medication therapy in patients with recurrent weight gain after sleeve gastrectomy. ...

Conversion surgery after active surveillance for low-risk papillary thyroid carcinoma (PTC) led to no clinically meaningful differences in outcomes as compared with immediate surgery, according to a ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — Results showed several surgical and patient factors were significantly associated with conversion from ...